- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 40/46 - Viral antigens
Patent holdings for IPC class A61K 40/46
Total number of patents in this class: 224
10-year publication summary
|
2
|
6
|
5
|
7
|
20
|
28
|
17
|
12
|
46
|
48
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| City of Hope | 1040 |
10 |
| The Council of the Queensland Institute of Medical Research | 165 |
8 |
| Memorial Sloan-Kettering Cancer Center | 2050 |
6 |
| Angeles Therapeutics, Inc. | 21 |
6 |
| STEMCELL Technologies Canada Inc. | 302 |
5 |
| The Regents of the University of California | 20802 |
4 |
| The General Hospital Corporation | 4869 |
4 |
| The Trustees of the University of Pennsylvania | 4426 |
4 |
| Baylor College of Medicine | 1007 |
4 |
| Emory University | 1725 |
4 |
| Regents of the University of Minnesota | 2794 |
4 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 3007 |
4 |
| Fred Hutchinson Cancer Center | 478 |
4 |
| American Gene Technologies International Inc. | 87 |
3 |
| Atara Biotherapeutics, Inc. | 63 |
3 |
| Dana-Farber Cancer Institute, Inc. | 2668 |
3 |
| Kite Pharma, Inc. | 451 |
3 |
| Koninklijke Nederlandse Akademie van Wetenschappen | 122 |
3 |
| NantKwest, Inc. | 48 |
3 |
| Wilson Wolf Manufacturing | 26 |
3 |
| Other owners | 136 |